BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25789418)

  • 21. Impact of scanning parameters and breathing patterns on image quality and accuracy of tumor motion reconstruction in 4D CBCT: a phantom study.
    Lee S; Yan G; Lu B; Kahler D; Li JG; Sanjiv SS
    J Appl Clin Med Phys; 2015 Nov; 16(6):195-212. PubMed ID: 26699574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of motion management parameters in a synchrotron-based spot scanning system.
    Johnson JE; Herman MG; Kruse JJ
    J Appl Clin Med Phys; 2019 Sep; 20(9):69-77. PubMed ID: 31538720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy.
    Li X; Kabolizadeh P; Yan D; Qin A; Zhou J; Hong Y; Guerrero T; Grills I; Stevens C; Ding X
    Radiat Oncol; 2018 Feb; 13(1):35. PubMed ID: 29486782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment planning and 4D robust evaluation strategy for proton therapy of lung tumors with large motion amplitude.
    Taasti VT; Hattu D; Vaassen F; Canters R; Velders M; Mannens J; van Loon J; Rinaldi I; Unipan M; van Elmpt W
    Med Phys; 2021 Aug; 48(8):4425-4437. PubMed ID: 34214201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breathing interplay effects during proton beam scanning: simulation and statistical analysis.
    Seco J; Robertson D; Trofimov A; Paganetti H
    Phys Med Biol; 2009 Jul; 54(14):N283-94. PubMed ID: 19550002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simulation of dosimetric consequences of 4D-CT-based motion margin estimation for proton radiotherapy using patient tumor motion data.
    Koybasi O; Mishra P; St James S; Lewis JH; Seco J
    Phys Med Biol; 2014 Feb; 59(4):853-67. PubMed ID: 24487573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4DMRI-based investigation on the interplay effect for pencil beam scanning proton therapy of pancreatic cancer patients.
    Dolde K; Zhang Y; Chaudhri N; Dávid C; Kachelrieß M; Lomax AJ; Naumann P; Saito N; Weber DC; Pfaffenberger A
    Radiat Oncol; 2019 Feb; 14(1):30. PubMed ID: 30732657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric uncertainties as a result of temporal resolution in 4D dose calculations for PBS proton therapy.
    Zhang Y; Huth I; Weber DC; Lomax AJ
    Phys Med Biol; 2019 Jun; 64(12):125005. PubMed ID: 31035271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of the delivered patient dose in lung IMRT treatment based on deformable registration of 4D-CT data and Monte Carlo simulations.
    Flampouri S; Jiang SB; Sharp GC; Wolfgang J; Patel AA; Choi NC
    Phys Med Biol; 2006 Jun; 51(11):2763-79. PubMed ID: 16723765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Multiple Beams on Plan Quality, Linear Energy Transfer Distribution, and Plan Robustness of Intensity Modulated Proton Therapy for Lung Cancer.
    Shang H; Pu Y; Chen Z; Wang X; Yuan C; Jin X; Liu C
    ACS Sens; 2021 Feb; 6(2):408-417. PubMed ID: 33125211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A method for selection of beam angles robust to intra-fractional motion in proton therapy of lung cancer.
    Casares-Magaz O; Toftegaard J; Muren LP; Kallehauge JF; Bassler N; Poulsen PR; Petersen JB
    Acta Oncol; 2014 Aug; 53(8):1058-63. PubMed ID: 24975371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motion effects in proton treatments of hepatocellular carcinoma-4D robustly optimised pencil beam scanning plans versus double scattering plans.
    Pfeiler T; Ahmad Khalil D; Ayadi M; Bäumer C; Blanck O; Chan M; Engwall E; Geismar D; Peters S; Plaude S; Spaan B; Timmermann B; Wulff J
    Phys Med Biol; 2018 Nov; 63(23):235006. PubMed ID: 30468685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
    Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study.
    Bowen SR; Nyflot MJ; Herrmann C; Groh CM; Meyer J; Wollenweber SD; Stearns CW; Kinahan PE; Sandison GA
    Phys Med Biol; 2015 May; 60(9):3731-46. PubMed ID: 25884892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplitude-based gated phase-controlled rescanning in carbon-ion scanning beam treatment planning under irregular breathing conditions using lung and liver 4DCTs.
    Mori S; Inaniwa T; Furukawa T; Takahashi W; Nakajima M; Shirai T; Noda K; Yasuda S; Yamamoto N
    J Radiat Res; 2014 Sep; 55(5):948-58. PubMed ID: 24835238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robustness of 4D-optimized scanned carbon ion beam therapy against interfractional changes in lung cancer.
    Graeff C
    Radiother Oncol; 2017 Mar; 122(3):387-392. PubMed ID: 28073579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technical challenges in the treatment of mediastinal lymphomas by proton pencil beam scanning and deep inspiration breath-hold.
    Righetto R; Fracchiolla F; Widesott L; Lorentini S; Dionisi F; Rombi B; Scartoni D; Vennarini S; Schwarz M; Farace P
    Radiother Oncol; 2022 Apr; 169():43-50. PubMed ID: 35189153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosimetric Benefits of Midposition Compared With Internal Target Volume Strategy for Esophageal Cancer Radiation Therapy.
    Jin P; Machiels M; Crama KF; Visser J; van Wieringen N; Bel A; Hulshof MCCM; Alderliesten T
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):491-502. PubMed ID: 30253234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.
    Sun Y; Ge H; Cheng S; Yang C; Zhu Q; Li D; Tian Y
    J Appl Clin Med Phys; 2016 Mar; 17(2):461-472. PubMed ID: 27074466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.